Showing posts with label FDA. Show all posts
Showing posts with label FDA. Show all posts

Saturday, February 26, 2011

Interview with Your Genetic Genealogist - Broadcast to over 50 million Japanese households


They came all the way from Japan to interview a handful of people from Stanford, Illumina, the FDA, the American Society of Genetic Counselors and...you guessed it,  me!  :-)

Earlier this month producers and crew from NHK Japan Broadcasting Corporation came to my home to tape a segment on personal genomics. (NHK is similar to PBS or the BBC.) The story is for a weekly news/documentary program entitled, CLOSE-UP TODAY. The entire program on one Saturday will be dedicated to genetic testing with a focus on DTC genetic testing.  As I understand it, the goal for this segment is to educate the Japanese public on DTC testing. I expect it to be a well rounded show since they were planning on interviewing the FDA, Illumina, physicians at Stanford University, a genetic testing company and genetic counselors. There will be some interviews with Japanese doctors and patients in the program as well. 

DTC genetic testing is still very rare in Japan, but there are companies starting to offer genetic tests to consumers there. They told me that the Japanese people tend to be pessimistic and give up easily when it comes to illness. In Japan, until recently, doctors and family members didn't even tell a person that he/she is terminally ill. Many Japanese people are concerned about getting a genetic test and feel they will be worried about their health all the time and get depressed if they find out they are at higher risk for certain diseases. Apparently, some Japanese physicians are also concerned about how to deal with genetic test results. The producers feel that consumers who take DTC tests need to know how to deal with their results and physicians also need to be trained to work with patients who come to them with test results. They want to encourage the Japanese public to be more positive and proactive in dealing with medical issues. 

The producers intend to show what the DTC genetic testing market is like in the US and demonstrate how Americans can be positive and proactive in dealing with test results, as well as what the experts are saying. They plan on using screenshots from my 23andMe account on air and I walked them through the large amount of health information and resources available from 23andMe. We also discussed some of the actions that I have taken due to my genetic test results.

They were here for a number of hours and we had a very enjoyable afternoon.  I don't know how much of it will make it past the editing room, but we had the opportunity to film a lot of really positive, constructive information. I, of course, could talk about this subject for hours! By the time we were finished, it seemed that all my visitors were interested in testing themselves. In fact, the director even offered to buy one of my unused 23andMe kits!

The show is scheduled to air on March 7th, but that could change depending on foreign affairs at that time. I wish I could ask all of you to watch it, but since I don't think many of my readers are in Japan, it would be in vain.  I have been promised a copy of the show and hope to be able to share it with you all at a later date.


Thursday, September 2, 2010

Sale and New Personal Genome Service Subscription at 23andMe

Today 23andMe has announced their new Personal Genome Service in conjunction with the sale price of $229 for either the Health or Ancestry Editions and $299 for the Complete Edition. In order to qualify for the sale price, the Health and Complete Editions require a minimum 3-month subscription commitment to this new service at $5/per month. Apparently, the Ancestry Edition does not. (This may lead to speculation that the new service has something to do with the impending FDA regulations.) Since this sale is a test it could end at any time.
A rep at 23andMe told me that the goal is "to get this (their product) into as many people's hands as possible, so we'll periodically do some testing of lower price points." Beyond that, the representative declined to elaborate at this time.